Please login to the form below

Not currently logged in
Email:
Password:

NHS

This page shows the latest NHS news and features for those working in and with pharma, biotech and healthcare.

NICE rejects Sanofi’s Dupixent for atopic dermatitis at first call

NICE rejects Sanofi’s Dupixent for atopic dermatitis at first call

A proposal by Sanofi to discount the cost to the NHS of its Dupixent drug for atopic dermatitis has not been enough to sway NICE, which has said it cannot back ... consider it a good use of NHS resources”.

Latest news

  • NHS seeks 'solution creators' from within pharma NHS seeks 'solution creators' from within pharma

    The NHS is moving into a new era of relations with the pharmaceutical industry, according to NHS England. ... However, he was clear about what NHS England wanted from the pharmaceutical industry.

  • EC grants MSD’s Prevymis orphan product designation EC grants MSD’s Prevymis orphan product designation

    According to the NHS, approximately 50-80% of adults in the UK are thought to have CMV, and once infected it can persevere in the body as an inactive or latent ... Houson continued: “This authorisation brings us a step closer to making letermovir

  • NICE backs GSK’s €594k gene therapy for rare disease NICE backs GSK’s €594k gene therapy for rare disease

    The guidance notes that “arrangements for NHS funding for travel and accommodation costs for people having Strimvelis and their families will be confirmed by NHS England”.

  • New NHS Alliance launches healthcare TV programme New NHS Alliance launches healthcare TV programme

    New NHS Alliance launches healthcare TV programme. In Search of Wellness follows those on a quest to improve healthcare. ... The New NHS Alliance has teamed up with ITN Productions to create a new healthcare-based TV programme called In Search of Wellness

  • Roche offers diabetes digital health programme to UK patients Roche offers diabetes digital health programme to UK patients

    OurPath has previously been offered either through the start-up’s own website or through small-scale NHS trials via GP surgeries in London. ... The firm said it wants to put more than 750, 000 people in the UK through the programme, in the process

More from news
Approximately 280 fully matching, plus 1,049 partially matching documents found.

Latest Intelligence

  • The challenges of making genomics a reality for patients The challenges of making genomics a reality for patients

    But only 5% of patients in England can currently access these medicines routinely through the NHS. ... Over the next seven years, Vertex anticipates submitting additional applications to the NHS for novel cystic fibrosis medicines or to extend the use of

  • A new era of smart pharma A new era of smart pharma

    It is expected that virtual doctors will save national health providers, such as the NHS, more than £20m per year and reduce the time spent on treating minor illnesses, currently costing ... the NHS around £2bn per year.

  • Six degrees of participation Six degrees of participation

    care.”. Degree #2: Understand all our audiences. It’s the best part of a decade since Andrew Lansley’s NHS reforms in the UK coined (or borrowed) the phrase ‘no decision

  • Digital health Digital health

    When she got her diagnosis she said that the NHS abandoned her.

  • The challenges of making genomics a reality for patients today, not tomorrow The challenges of making genomics a reality for patients today, not tomorrow

    But only 5% of patients in England can currently access these medicines routinely through the NHS. ... Over the next seven years, Vertex anticipates submitting additional applications to the NHS for novel cystic fibrosis medicines or to extend the use of

More from intelligence
Approximately 20 fully matching, plus 106 partially matching documents found.

Latest appointments

More from appointments
Approximately 19 fully matching, plus 82 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 22 fully matching, plus 159 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
BASTARD . LONDON

BASTARD . LONDON collaborates with you to amplify brand ideas into a visual brand language that resonates and engages with...

Latest intelligence

The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
Unique forum will unite NHS and industry to drive innovation
HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare...

Infographics